| Literature DB >> 27117414 |
Aaron Topol1, Shijia Zhu2, Brigham J Hartley3, Jane English4, Mads E Hauberg5, Ngoc Tran1, Chelsea Ann Rittenhouse1, Anthony Simone6, Douglas M Ruderfer1, Jessica Johnson1, Ben Readhead2, Yoav Hadas1, Peter A Gochman7, Ying-Chih Wang2, Hardik Shah2, Gerard Cagney8, Judith Rapoport7, Fred H Gage6, Joel T Dudley2, Pamela Sklar1, Manuel Mattheisen5, David Cotter4, Gang Fang9, Kristen J Brennand10.
Abstract
Converging evidence indicates that microRNAs (miRNAs) may contribute to disease risk for schizophrenia (SZ). We show that microRNA-9 (miR-9) is abundantly expressed in control neural progenitor cells (NPCs) but also significantly downregulated in a subset of SZ NPCs. We observed a strong correlation between miR-9 expression and miR-9 regulatory activity in NPCs as well as between miR-9 levels/activity, neural migration, and diagnosis. Overexpression of miR-9 was sufficient to ameliorate a previously reported neural migration deficit in SZ NPCs, whereas knockdown partially phenocopied aberrant migration in control NPCs. Unexpectedly, proteomic- and RNA sequencing (RNA-seq)-based analysis revealed that these effects were mediated primarily by small changes in expression of indirect miR-9 targets rather than large changes in direct miR-9 targets; these indirect targets are enriched for migration-associated genes. Together, these data indicate that aberrant levels and activity of miR-9 may be one of the many factors that contribute to SZ risk, at least in a subset of patients.Entities:
Keywords: human-induced pluripotent stem cell; microRNA-9; neural progenitor cells; schizophrenia
Mesh:
Substances:
Year: 2016 PMID: 27117414 PMCID: PMC4856588 DOI: 10.1016/j.celrep.2016.03.090
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423